HHS sends White House a plan to let pharmacies compound peptides like BPC-157
The interim policy would ease enforcement on compounding pharmacies making select peptides, per two people familiar with it. FDA scientists had cited thin human safety data.
Recap by typeshit. Full story at Yahoo.